Rezolute, Inc.

US$3.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RZLTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (23.91%)
Div yield —
ROE (66.85%)
Biotechnology
Beta (5Y) 0.62
PE TTM —
TSR TTM (58.37%)
Mkt cap US$407.0M
ROIC (43.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.39
13.26%
182.76%
Sell 0|2|2|2|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.06
0.07
0.07
0.08
30.40%
32.47%
30.52%
36.82%
Revenue$M
26.31
25.68
26.69
26.63
(0.36%)
(3.33%)
0.02%
(1.73%)
Peers (US$407.0M)
Cap (US$)
PE
404.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.229
0.034
0.030
EBIT/Intx
0.693
0.425
0.335
Own earn%
35.01
151.59
154.87
Sh yield%
28.43
18.00
15.76
Owners
Insiders/Inst%
9.26
60.16
Short interest%
2.13
SBC / revenue%
4.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
3–11
$1 testx
0.0
Incr. ROIC%
8